Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Hawaii Biotech
company
About
Hawaii Biotech, Inc., a biotechnology company, focuses on the research and development of prophylactic vaccines for infectious diseases.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series A
- Industries
- Biotechnology,Health Care,Medical Device
- Founded date
- Jan 1, 1982
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Hawaii Biotech, Inc., a biotechnology company, focuses on the research and development of prophylactic vaccines for infectious diseases. It provides a protein production platform that has application to the production of proteins for use as antigens in infectious disease vaccines. The company also develops vaccines for various diseases, including West Nile, influenza, dengue fever, hepatitis C, malaria, Japanese encephalitis, Ebola, and Eastern equine encephalitis. Hawaii Biotech, Inc. was founded in 1982 and is based in Aiea, Hawaii.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Hawaii Biotech has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
Mar 31, 2004 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 31, 2004 | Series A | — | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Hawaii Biotech is funded by 1 investors.
Advantage Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Advantage Capital
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
